Male Infertility Related With Post Infection Inflammatory Syndrome
NCT01407484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-04-03
Summary
BACKGROUND: One couple out of 6 consults for infertility during their sexual life. In 60% of cases a male factor is associated or is the main infertility factor. Inflammatory Syndrome (IS), characterized by the presence of a leukocytospermia is found in 12% of the cases. Leukocyte degranulation causes oxidative stress (OS) through the formation of free radicals attacking the sperm cell functions.
HYPOTHESIS: To establish the responsibility of the IS, and OS, in chronicle inflammatory male infertility, the investigators hypothesize that its treatment (as well as its possible cause) must restore or improve the fertilizing capacity of patients sperm.
METHODS: This prospective randomized study will test the response to the treatment. The investigators shall measure cellular degradation products due to the OS, thereby certifying that it does have a deleterious effect on sperm cell. Seminal biochemistry will also assess the impact of the syndrome on the genital tract glands and follow its evolution.
The patients will be included in the study as soon as the leukocytospermia will be \> 0,5\*106/ml or as soon as the elastase will be \> 500 ng/mL.
The examinations will be performed using flow cytometry, CASA (Computer Assisted Semen Analysis). The analysis of sperm morphology will be centralized.
Primary endpoint will be a reduction in the percentage of 8OH-dG below 35 %. We anticipate that it should arrive to 20 % of the patients included in the arm treatment by corticosteroid therapy. All in all will thus be needed 50 patients in the group placebo and 50 in the group treated.
Secondary endpoint the improvement of the spermatic parameters and the reduction of the fragmentation of the DNA of sperm cells to the treated subjects.
All these biological markers will be evaluated 6 month after the treatment:
* Fragmentation of the spermatic DNA below 37 % during the follow-up in 6 months
* Leukocytospermia and elastase
* Seminal biochemistry
* Other markers of the inflammatory syndrome and oxidative stress (protein carbonyl, 8OHd-Guanosine)
* Possibly the radiological examinations (Ultrasound and MRI of the genital tract)
In addition it would allow us to propose a policy of prevention towards acquired post-infectious male infertility.
Conditions
- Male Infertility
- Leukopenia
- Postinfection Inflammation
- Oxidative Stress
Interventions
- DRUG
-
0,2 mg/kg/day for 3 weeks and 0,1mg/kg/day for 1 week.
- DRUG
-
Placebo 0,2 mg/kg/day for 3 weeks and 0,1mg/kg/day for 1 week
Sponsors & Collaborators
-
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jean-Philippe Wolf, MD, Phd · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-02
- Primary Completion
- 2015-05-14
- Completion
- 2015-05-14
Countries
- France
Study Locations
More Related Trials
-
Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization Cycles
NCT01560065 ·Status: COMPLETED ·Phase: PHASE4
-
Myo-inositol on Human Semen Parameters
NCT01828710 ·Status: COMPLETED ·Phase: NA
-
Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies
NCT02935738 ·Status: COMPLETED ·Phase: NA
-
Denosumab and Male Infertility: a RCT
NCT03030196 ·Status: COMPLETED ·Phase: PHASE2
-
Determining the Reproductive Health of Men Post-COVID-19 Infection
NCT04414904 ·Status: WITHDRAWN
-
Effect of Graminex on Infertility Related to Male Accessory Glands Inflammation
NCT06974175 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of A Nutritional Supplements' Combination (FERTILIS) on Male Infertility
NCT04193358 ·Status: UNKNOWN ·Phase: NA
-
Supplement Intake in Infertile Men;the Effect on Sperm Parameters,Fertilization Rate and Embryo Quality
NCT01520584 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of SiD's System for Improving Assisted Reproduction Treatments
NCT05611164 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males
NCT01793272 ·Status: COMPLETED ·Phase: NA
-
Metabolic Syndrome and Male Infertility
NCT01974947 ·Status: COMPLETED
-
Proposed Research Protocol For Male Infertility
NCT01255397 ·Status: UNKNOWN ·Phase: NA
-
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243 ·Status: COMPLETED
-
Platelet Rich Plasma Testis Treatment for Infertile Men
NCT05479474 ·Status: RECRUITING ·Phase: NA
-
Preimplantation Genetic Screening in Patients With Male Factor Infertility
NCT02941965 ·Status: UNKNOWN ·Phase: NA
-
Effect of Omega 3 Fats on Sperm Quality and Sexual Function
NCT00406874 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
NCT04142112 ·Status: UNKNOWN ·Phase: NA
-
Level of DNA-fragmentation Before and After Antioxidant-based Therapies in Male Infertility
NCT06050031 ·Status: NOT_YET_RECRUITING
-
Aromatase Inhibitors in the Treatment of Male Infertility
NCT00440180 ·Status: TERMINATED ·Phase: PHASE3
-
Association Study Between Periodontal Disease and Male Infertility
NCT01140945 ·Status: COMPLETED
-
In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility
NCT04128904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Oxidative Stress and Male Infertility.
NCT06210568 ·Status: RECRUITING
-
Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters
NCT04937608 ·Status: TERMINATED
-
Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells
NCT03615547 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Power Prenatal Supplements for Sperm Quality
NCT05410782 ·Status: RECRUITING ·Phase: NA